Radiation therapy of primary vaginal carcinoma

Int J Radiat Oncol Biol Phys. 1983 Oct;9(10):1471-5. doi: 10.1016/0360-3016(83)90320-6.

Abstract

Primary carcinoma of the vagina is rare, constituting only 1 to 2% of all neoplasms arising in the female genital tract. From 1950-1974, 36 patients with carcinoma of the vagina were treated with radiation at Memorial Sloan-Kettering Cancer Center (MSKCC); 35 (96%) had epidermoid carcinoma and one patient (4%) had adenocarcinoma. These patients were staged according to FIGO. Fourteen patients (39%) were Stage I; six patients (17%) were Stage II; three patients (8%) were Stage III; and 13 patients (36%) were Stage IV. Nine patients (25%) were treated with external radiation and interstitial implant; seven patients (20%) were treated with interstitial implant alone; nine patients (25%) were treated with external radiation alone and 11 patients (30%) with external radiation and intracavitary radiation. The five year NED survival was 71% in Stage I, 66% in Stage II, 33% in Stage III and 0% in Stage IV. This paper discusses radiotherapy management of primary carcinoma of the vagina.

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / radiotherapy*
  • Adult
  • Aged
  • Brachytherapy
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / radiotherapy*
  • Cobalt Radioisotopes / therapeutic use
  • Female
  • Humans
  • Iodine Radioisotopes / therapeutic use
  • Iridium / therapeutic use
  • Middle Aged
  • Radioisotope Teletherapy
  • Radioisotopes / therapeutic use
  • Radiotherapy Dosage
  • Radium / therapeutic use
  • Vaginal Neoplasms / mortality
  • Vaginal Neoplasms / radiotherapy*

Substances

  • Cobalt Radioisotopes
  • Iodine Radioisotopes
  • Radioisotopes
  • Iridium
  • Radium